Back to search

Migration Biotherapeutics Limited

14182892

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

4TH FLOOR, 14 MUSEUM PLACE, CARDIFF, CF10 3BH
Incorporated 20/06/2022

Compliance

Last accounts

30/06/2025

micro entity

Next accounts due

31/03/2027

On track

Confirmation statement

Last: 19/06/2025

Due 03/07/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Professor Peter Romilly Bannister

director · Since 20/06/2022

BUSINESS EXECUTIVE

BRITISH · WALES · Age 49

Also on 3 other boards

Davide Danovi

director · Since 20/06/2022

BUSINESS EXECUTIVE

ITALIAN,BRITISH · ENGLAND · Age 51

Dr Emilie Claudine Jennifer Syed

director · Since 19/12/2025

FRENCH,BANGLADESHI · UNITED KINGDOM · Age 44

Also on 3 other boards

Dr Alan M Ezrin

director · Since 05/03/2026

AMERICAN · UNITED STATES · Age 74

Persons with Significant Control

Professor Peter Romilly Bannister

25–50% shares
25–50% votes
Appoint directors

British · Wales · Age 49

4th Floor, 14, Museum Place, Cardiff, CF10 3BH

Notified 20/06/2022

Davide Danovi

25–50% shares
25–50% votes
Appoint directors

Italian,British · England · Age 51

85, Calshot Street, London, N1 9AR

Notified 20/06/2022

CompanyRankvs 38290+ SIC 72110 peers
25

Financial strength17th percentile among SIC peers · 4/25
Employees0th percentile among SIC peers · 0/15
LiquidityCurrent ratio 0.46× · 2/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength4/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/06/2025

Net Worth

-£5k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£4k

Working capital

Current Assets

£4k

Current Liabilities

£8k

Balance Sheet

Assets less current liabilities-£4k
Signed by Prof P R Bannister Mr D Danovi 11/03/2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.46+£0
20250.46

Derived from filed accounts. Not audited figures.